A detailed history of Hughes Financial Services, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Hughes Financial Services, LLC holds 10 shares of HALO stock, worth $533. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Holding current value
$533
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 01, 2025

BUY
$47.74 - $65.16 $477 - $651
10 New
10 $619,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $7.42B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Hughes Financial Services, LLC Portfolio

Follow Hughes Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hughes Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hughes Financial Services, LLC with notifications on news.